AMG 701, a half-life extended anti-BCMA BiTE®, potently induces T cell-redirected lysis of human multiple myeloma cells and can be combined with IMiDs to overcome the immunosuppressive bone marrow microenvironment
Clinical Lymphoma Myeloma and Leukemia（2019）
关键词
B-cell maturation antigen,BiTE (R) (Bispecific T-cell Engager) molecule,immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要